Back to CITADEL ADVISORS LLC

DSGN
Showing 8 of 21 quarters

Position history for CITADEL ADVISORS LLC's holdings in DESIGN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 231,513 shares of DSGN (DESIGN THERAPEUTICS INC), worth $2.5M as of 2026-Q1. The position was decreased (-49.7% shares). DSGN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.5M

Current Shares

231,513

Total Value Change

+$1.4M

Total Shares Change

-73,117

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
231,513
-49.7%
$2.5M0.0%$10.00
0
2025-Q4
Decreased
459,874
-17.0%
$4.3M0.0%$9.79
0
2025-Q3
Decreased
554,020
-34.1%
$4.2M0.0%$6.85
0
2025-Q2
Decreased
840,793
-12.7%
$2.8M0.0%$3.57
0
2025-Q1
Increased
963,460
+0.5%
$3.7M0.0%$4.21
27
2024-Q4
Increased
958,793
+66.6%
$5.9M0.0%$6.17
40
2024-Q3
Increased
575,550
+88.9%
$3.1M0.0%$5.33
41
2024-Q2
Decreased
304,630
-65.2%
$1M0.0%$3.35
0

Other major holders of DSGN: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used